Drug: Cerumenex

CERUMENEX Eardrops contain triethanolamine Polypeptide Oleate-Condensate (10%). Inactive Ingredients: Chlorobutanol 0.5%, Propylene Glycol and Water. Triethanolamine Polypeptide Oleate is a hygroscopic-miscible solution with low surface tension and optimal viscosity of 50-90 cps. It also has a slightly acid pH range (5.0-6.0) to approximate the surface of a normal ear canal.

Source: http://www.rxlist.com

Clinical Reactions of Possible Allergic Origin Localized dermatitis reactions were reported in about 1% of 2,700 patients treated, ranging from a very mild erythema and pruritus of the external canal to a severe eczematoid reaction involving the external ear and periauricular tissue, generally with duration of 2-10 days. Other reactions which have been reported in connection with the use of CERUMENEX (triethanolamine polypeptide) Eardrops include allergic contact dermatitis, skin ulcerations, burning and pain at the application site and skin rash. Read the Cerumenex (triethanolamine polypeptide) Side Effects Center for a complete guide to possible side effectsLearn More »

Source: http://www.rxlist.com

  1. Fill ear canal with CERUMENEX (triethanolamine polypeptide) Eardrops with the patient's head tilted at a 45° angle.
  2. Insert cotton plug and allow to remain 15-30 minutes.
  3. then gently flush with lukewarm water, using a soft rubber syringe (avoid excessive pressure). Exposure of skin outside the ear to the drug should be avoided. The procedure may be repeated if the first application fails to clear the impaction.
FOR EXTERNAL USE IN THE EAR ONLY

Source: http://www.rxlist.com

No information provided. Last reviewed on RxList: 4/27/2009
This monograph has been modified to include the generic and brand name in many instances.

Source: http://www.rxlist.com

For removal of impacted cerumen prior to ear examination, otologic therapy and/or audiometry.

Source: http://www.rxlist.com

Perforated tympanic membrane or otitis media is considered a contraindication to the use of this medication in the external ear canal. A history of hypersensitivity to CERUMENEX (triethanolamine polypeptide) Eardrops or to any of its components is also a contraindication to the use of this medication.Last reviewed on RxList: 4/27/2009
This monograph has been modified to include the generic and brand name in many instances.

Source: http://www.rxlist.com

No information provided.

Source: http://www.rxlist.com

CERUMENEX (triethanolamine polypeptide) Eardrops (triethanolamine polypeptide oleate-condensate) are supplied in 6 mL (NDC 0034-5490-06) and 12 mL (NDC 0034-5490-12) bottles with a cellophane wrapped dropper. Store at controlled room temperature 15-30°C (59-86°F). Store in a dry place. The Purdue Frederick Company Stamford, CT 06901-3431. November 13, 2001. Last reviewed on RxList: 4/27/2009
This monograph has been modified to include the generic and brand name in many instances.

Source: http://www.rxlist.com

General It is recommended that the following precautions be observed in prescribing and administration of this agent:
  1. Extreme caution is indicated in patients with demonstrable dermatologic idiosyncrasies or with history of allergic reactions in general.
  2. Exposure of the ear canal to the CERUMENEX (triethanolamine polypeptide) Eardrops should be limited to 15-30 minutes.
  3. When administering CERUMENEX (triethanolamine polypeptide) Eardrops, care must be taken to avoid undue exposure of the skin outside the ear during the instillation and the flushing out of the medication. If the medication comes in contact with the skin, the area should be washed with soap and water. Use of proper technique (see DOSAGE AND ADMINSITRATION) will help avoid such undue exposure.
  4. CERUMENEX (triethanolamine polypeptide) Eardrops should be used only with caution in external otitis.
Carcinogenesis, Mutagenesis, Impairment of Fertility Long-term animal studies have not been performed to evaluate the carcinogenic potential or the effect on fertility of CERUMENEX (triethanolamine polypeptide) Eardrops. Pregnancy Teratogenic Effects: Pregnancy Category C. Animal reproduction studies have not yet been conducted with CERUMENEX (triethanolamine polypeptide) Eardrops. It is also not known whether CERUMENEX (triethanolamine polypeptide) Eardrops can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. CERUMENEX (triethanolamine polypeptide) Eardrops should be given to a pregnant woman only if clearly needed. Nursing Mothers It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when CERUMENEX (triethanolamine polypeptide) Eardrops are administered to a nursing mother. Pediatric Use Safety and effectiveness in children have not been established. Geriatric Use No overall clinical differences in safety or effectiveness have been observed between the elderly and other adult patients. Last reviewed on RxList: 4/27/2009
This monograph has been modified to include the generic and brand name in many instances.

Source: http://www.rxlist.com

Health Services in

Drug Database Online

Welcome to Senior Healthcare Matters an online drug guide and dictionary, here you can get drug information and definitaions for most popular pharmaceutical and medicinal drugs, and specifically Cerumenex. Find what medications you are taking today.